TW200612983A - Vaccine - Google Patents
VaccineInfo
- Publication number
- TW200612983A TW200612983A TW094119691A TW94119691A TW200612983A TW 200612983 A TW200612983 A TW 200612983A TW 094119691 A TW094119691 A TW 094119691A TW 94119691 A TW94119691 A TW 94119691A TW 200612983 A TW200612983 A TW 200612983A
- Authority
- TW
- Taiwan
- Prior art keywords
- hpv
- composition
- types
- cancer
- vaccine
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 3
- 201000011510 cancer Diseases 0.000 abstract 3
- 230000002163 immunogen Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
An immunogenic composition and methods for producing said composition, the composition comprising VLPs from HPV 16 and 18 and at least one other HPV cancer type, the other cancer type being selected from the list consisting of HPV types 31, 45 and 52, wherein the dose of the VLP of the at least one other cancer types is reduced relative to that of HPV 16 or 18.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0413510.9A GB0413510D0 (en) | 2004-06-16 | 2004-06-16 | Vaccine |
US11/114,301 US20050287161A1 (en) | 2002-12-20 | 2005-04-26 | Vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200612983A true TW200612983A (en) | 2006-05-01 |
Family
ID=32750044
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW094119691A TW200612983A (en) | 2004-06-16 | 2005-06-14 | Vaccine |
Country Status (15)
Country | Link |
---|---|
JP (1) | JP2012102132A (en) |
KR (1) | KR101359943B1 (en) |
CN (1) | CN1976718B (en) |
CY (1) | CY1113830T1 (en) |
DK (1) | DK1758609T3 (en) |
ES (1) | ES2394448T3 (en) |
GB (1) | GB0413510D0 (en) |
HR (1) | HRP20120930T1 (en) |
HU (3) | HUS1500061I1 (en) |
LT (1) | LTC1758609I2 (en) |
NL (3) | NL300771I2 (en) |
PT (1) | PT1758609E (en) |
SI (1) | SI1758609T1 (en) |
TW (1) | TW200612983A (en) |
ZA (1) | ZA200610057B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2416798B1 (en) * | 2009-04-10 | 2017-09-20 | The Johns Hopkins University | Papillomavirus-like particles (vlp) as broad spectrum human papillomavirus (hpv) vaccines |
NZ606949A (en) * | 2010-07-15 | 2015-11-27 | British Columbia Cancer Agency | Human papillomavirus e7 antigen compositions and uses thereof |
CN107188966B (en) | 2016-03-15 | 2020-03-31 | 中国医学科学院基础医学研究所 | Papilloma virus chimeric protein and application thereof |
CN114539365B (en) * | 2020-11-26 | 2023-12-01 | 中国医学科学院基础医学研究所 | Modified human papilloma virus 52 type L1 protein and application thereof |
CN114716561B (en) | 2021-01-04 | 2024-03-12 | 中国医学科学院基础医学研究所 | Human papilloma virus 31 chimeric protein and application thereof |
CN114716560B (en) | 2021-01-04 | 2024-02-02 | 中国医学科学院基础医学研究所 | Human papilloma virus 18 chimeric protein and application thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9921146D0 (en) * | 1999-09-07 | 1999-11-10 | Smithkline Beecham Biolog | Novel composition |
GB9921147D0 (en) * | 1999-09-07 | 1999-11-10 | Smithkline Beecham Biolog | Novel composition |
GB0110431D0 (en) * | 2001-04-27 | 2001-06-20 | Glaxosmithkline Biolog Sa | Novel compounds |
GB0206359D0 (en) * | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
GB0206360D0 (en) * | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
-
2004
- 2004-06-16 GB GBGB0413510.9A patent/GB0413510D0/en not_active Ceased
-
2005
- 2005-06-14 CN CN2005800195155A patent/CN1976718B/en active Active
- 2005-06-14 DK DK05757953.4T patent/DK1758609T3/en active
- 2005-06-14 TW TW094119691A patent/TW200612983A/en unknown
- 2005-06-14 SI SI200531633T patent/SI1758609T1/en unknown
- 2005-06-14 ES ES05757953T patent/ES2394448T3/en active Active
- 2005-06-14 PT PT57579534T patent/PT1758609E/en unknown
- 2005-06-14 KR KR1020127027786A patent/KR101359943B1/en active IP Right Grant
-
2006
- 2006-11-30 ZA ZA200610057A patent/ZA200610057B/en unknown
-
2012
- 2012-01-06 JP JP2012001102A patent/JP2012102132A/en active Pending
- 2012-11-16 HR HRP20120930TT patent/HRP20120930T1/en unknown
- 2012-12-11 CY CY20121101211T patent/CY1113830T1/en unknown
-
2015
- 2015-11-30 NL NL300771C patent/NL300771I2/nl unknown
- 2015-11-30 NL NL300773C patent/NL300773I2/nl unknown
- 2015-11-30 NL NL300774C patent/NL300774I2/nl unknown
- 2015-12-01 HU HUS1500061C patent/HUS1500061I1/en unknown
- 2015-12-01 HU HUS1500060C patent/HUS1500060I1/en unknown
- 2015-12-01 HU HUS1500059C patent/HUS1500059I1/en unknown
- 2015-12-07 LT LTPA2015046C patent/LTC1758609I2/en unknown
Also Published As
Publication number | Publication date |
---|---|
HRP20120930T1 (en) | 2012-12-31 |
KR101359943B1 (en) | 2014-02-10 |
CY1113830T1 (en) | 2016-06-22 |
NL300771I1 (en) | 2015-12-29 |
KR20120123617A (en) | 2012-11-08 |
ES2394448T3 (en) | 2013-01-31 |
NL300774I1 (en) | 2015-12-29 |
DK1758609T3 (en) | 2012-12-10 |
NL300773I1 (en) | 2015-12-29 |
NL300773I2 (en) | 2015-12-29 |
JP2012102132A (en) | 2012-05-31 |
SI1758609T1 (en) | 2013-01-31 |
LTC1758609I2 (en) | 2017-05-10 |
CN1976718A (en) | 2007-06-06 |
HUS1500059I1 (en) | 2017-10-30 |
GB0413510D0 (en) | 2004-07-21 |
PT1758609E (en) | 2012-12-21 |
CN1976718B (en) | 2012-10-10 |
HUS1500060I1 (en) | 2017-10-30 |
NL300771I2 (en) | 2015-12-29 |
HUS1500061I1 (en) | 2016-01-28 |
ZA200610057B (en) | 2008-02-27 |
NL300774I2 (en) | 2015-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006037787A3 (en) | Vlp-antigen conjugates and their uses as vaccines | |
SG153837A1 (en) | Vaccine against hpv16 and hpv18 and at least another hpv type selected from hpv 31, 45 or 52 | |
MY139031A (en) | Vaccine composition comprising virus-like particles of human papillomavirus | |
TW200612983A (en) | Vaccine | |
WO2005013901A3 (en) | Oligomeric compounds and compositions for use in modulation of small non-coding rnas | |
WO2005056759A3 (en) | Methods of generating variant proteins with increased host string content and compositions thereof | |
MY139500A (en) | Optimized expression of hpv 58 l1 in yeast | |
WO2007024941A3 (en) | Polyvalent vaccine | |
WO2007095976A3 (en) | Adjuvant in the form of a lipid-modified nucleic acid | |
TW200716646A (en) | (S)-N-methylnaltrexone | |
WO2008024302A3 (en) | Compounds for treating proliferative disorders | |
WO2008057550A3 (en) | Stabilization of vaccines by lyophilization | |
MX2011008649A (en) | Inactivated dengue virus vaccine with aluminium-free adjuvant. | |
WO2006076003A3 (en) | Vaccinia virus strains | |
WO2012165815A3 (en) | Nano-vehicle derived from tumor tissue, and cancer vaccine using same | |
NZ579478A (en) | Epha3 antibodies for the treatment of solid tumors | |
BRPI0810959A2 (en) | "hpv11 l1 protein, polynucleotide, vector, cell, composition, virus-like particle (vlp) hp11, method for producing an hpv l1 protein, vaccine for prevention of acuminate condyloma or hpv infections, use of the protein prevention method of acuminate condyloma or hpv infections and method for prevention of acuminate condyloma or hpv infections. | |
GB0320020D0 (en) | Improved formulation for providing an enteric coating material | |
MX2022009964A (en) | Hpv vaccine. | |
WO2005058356A3 (en) | Methods for porducing storage stable viruses and immunogenic compositions thereof | |
EP4248992A3 (en) | Foot-and-mouth disease vaccine | |
WO2005017130A3 (en) | Tumour cell lines nm-f9 (dsm acc2606) and nm-d4 (dsm acc2605), uses thereof | |
BRPI0818718B8 (en) | process of preparing a vaccine composition comprising antigen and adjuvant in the form of inverse latex of acrylic acid homopolymer | |
SG149058A1 (en) | Live genetically attenuated malaria vaccine | |
WO2006105255A3 (en) | Cancer vaccines and therapeutic methods |